Women with Ehlers-Danlos Syndrome Experience Low Oral Health–Related Quality of Life

Aims: To investigate the perceived impact of oral health-related quality of life problems in individuals with Ehlers-Danlos syndrome. Methods: Members of the Swedish Ehlers-Danlos Syndrome Association completed the Oral Health Impact Profile (OHIP-14). Of the 250 participating individuals, 223 were women, and they were the main focus of the analyses. The results were compared with a previous study of the oral health impact on quality of life in the Swedish population. Statistical methods used for comparison were the Student t and chi-square tests. Results: The mean OHIP-14 value for the entire Ehlers-Danlos syndrome group was 11.1. The mean for women was 11.8, which was significantly higher than 6.8 of the comparison group. The OHIP-14 score varied among age groups, and the highest mean value was found in the age group between 56 and 65 years of age. The most statistically significant differences between the subjects with Ehlers-Danlos syndrome and the comparison group were found for OHIP items 3, 4, and 8: "I have had pain in the mouth," "I have had discomfort when eating," and "I have been forced to interrupt meals." Conclusion: It is well-known that Ehlers-Danlos syndrome has a considerable impact on health-related quality of life, and this study is the first to reveal that women with Ehlers-Danlos syndrome report a low oral health-related quality of life as measured with the OHIP-14. Dimensions that were particularly relevant were physical pain, psychologic discomfort, and handicap.

disability; Ehlers-Danlos syndrome; functional limitation; OHIP-14; oral health; quality of life

1. Steinmann B, royce PM, Superti-furga a. The Ehlers-Dan- los syndrome. in: royce PM, Steinmann B (eds). connective Tissue and its Heritable Disorders. Molecular, Genetic, and Molecular aspects. new York: Wiley-Liss, 1997:351–407.

2. callewaert B, Malfait f, Loeys B, De Paepe a. Ehlers-Dan- los syndromes and Marfan syndrome. Best Pract res clin rheumatol 2008;22:165–189.

3. Beighton P, de Paepe a, Danks D, et al. international nosology of heritable disorders of connective tissue, Berlin, 1986. am J Med Genet 1988;29:581–594.

4. Beighton P, De Paepe a, Steinmann B, Tsipouras P, Wen- strup rJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. am J Med Genet 1998;77:31–37.

5. Malfait f, Wenstrup rJ, De Paepe a. clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet Med 2010;12:597–605.

6. Berglund B, nordström G, Lützén K. Living a restricted life with Ehlers-Danlos syndrome (EDS). int J nurs Stud 2000;37:111–118.

7. Voermans nc, Knoop H, Bleijenberg G, van Engelen BG. Pain in Ehlers-Danlos syndrome is common, severe, and associated with functional impairment. J Pain Symptom Manage 2010;40:370–378.

8. Sacheti a, Szemere J, Bernstein B, Tafas T, Schechter n, Tsipouras P. chronic pain is a manifestation of Ehlers-Dan- los syndrome. J Pain Symptom Man 1997;14:88–93.

9. Yassin OM, rihani fB. Multiple developmental dental anomalies and hypermobility type Ehlers-Danlos syndrome. J clin Pedriatr Dent 2006;30:337–341.

10. De coster PJ, Martens Lc, De Paepe a. Oral health in prevalent types of Ehlers-Danlos syndrome. J Oral Pathol Med 2005;34:298–307.

11. Klingberg G, Hagberg c, norén JG, nietzsche S. aspects on dental hard tissues in primary teeth from patients with Ehlers-Danlos syndrome. int J Paedriatr Dent 2009;19: 282–290.

12. Hagberg c, Berglund B, Korpe L, andersson-norinder

J. Ehlers-Danlos syndrome (EDS) focusing on oral symptoms: a questionnaire study. Orthod craniofac res 2004;7: 178–185.

13. Einarson S, Gerdin EW, Hugoson a. Oral health impact on quality of life in an adult Swedish population. acta Odontol Scand 2009;67:85–93.

14. Slade GD. Derivation and validation of a short-form oral health impact profile. community Dent Oral Epidemiol 1997;25:284–290.

15. World Health Organization. Oral Health Surveys Basic Methods, ed 4. Geneva: WHO, 1997.

16. Hägglin c, Berggren U, Hakeberg M, Edvardsson a, Eriksson M. Evaluation of a Swedish version of the OHiP-14 among patients in general and specialist dental care. Swed Dent J 2007;31:91–101.

17. abel MD, carrasco Lr. Ehlers-Danlos syndrome: classifications, oral manifestations, and dental considerations. Oral Surg Oral Med Oral Pathol Oral radiol Endod 2006;102:582–590.

18. Voermans nc, Knoop H, van de Kamp n, Hamel Bc, Blei- jenberg G, van Engelen BG. fatigue is a frequent and clinically relevant problem in Ehlers-Danlos syndrome. Semin arthritis rheum 2010;40:267–274.

19. Voermans nc, Knoop H, Bleijenberg G, van Engelen BG. fatigue is associated with muscle weakness in Ehlers-Dan- los syndrome. Physiotherapy 2011;97:170–174.

20. rombaut L, Malfait f, cools a, de Paepe a, calders P. Mus- culoskeletal complaints, physical activity and health-relat- ed quality of life among patients with the Ehlers-Danlos syndrome hypermobility type. Disabil rehabil 2010;32: 1339–1345.

21. castori M, camerota f, celletti c, Grammatico P, Padua

L. Quality of life in the classic and hypermobility types of Ehlers-Danlos syndrome. ann neurol 2010;67:145–146.

22. arendt-nielsen L, Kaalund S, Bjerring P, Høgsaa B. insufficient effect of local analgesics in Ehlers-Danlos syndrome type iii patients (connective tissue disorder). acta anaesthesiol Scand 1990;34:358–361.

23. Tabolli S, Bergamo f, alessandroni L, Di Pietro c, Sampogna f, abeni D. Quality of life and psychological problems of patents with oral mucosal disease in dermatological practice. Dermatology 2009;218:314–320.

24. Skuladottir H, Halldorsdottir S. Women in chronic pain: Sense of control and encounters with health professionals. Qual Health res 2008;18:891–901.

25. rombaut L, Malfait f, De Wandele i, et al. Medication, surgery, and physiotherapy among patients with the hyper- mobility type of Ehlers-Danlos syndrome. arch Phys Med rehabil 2011;92:1106–1112.